CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are moving higher Monday after the company presented preclinical data for its lead compound.
CERo Therapeutics Stock Is Soaring Monday: What’s Going On?
Where Today's News Shapes Tomorrow
December 15, 2025
Headlines
